Reneo Pharmaceuticals, Inc.
RPHM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $111 | $28 | $20 | $125 |
| Short-Term Investments | $0 | $75 | $81 | $23 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $4 | $5 | $6 |
| Total Curr. Assets | $113 | $107 | $106 | $154 |
| Property Plant & Equip (Net) | $2 | $1 | $2 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $1 | $2 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $115 | $107 | $108 | $154 |
| Liabilities | – | – | – | – |
| Payables | $3 | $9 | $2 | $2 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $9 | $5 | $4 |
| Total Curr. Liab. | $11 | $18 | $7 | $6 |
| LT Debt | $1 | $1 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $0 |
| Total Liabilities | $11 | $19 | $8 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $115 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$155 | -$218 | -$137 | -$85 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $259 | $307 | $237 | $232 |
| Total Equity | $104 | $89 | $100 | $147 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $115 | $107 | $108 | $154 |
| Net Debt | -$110 | -$27 | -$18 | -$125 |